Subsequently, an authoritative independent validation dataset showed that these 4 genes have good risk prediction capabilities for HCC (p = 0.011, AUC > 0.67), while a high TRMT6 level was related to poor prognosis (p = 0.014) (Safra et al., 2017). This evidence concerns the gene TRMT6 and hepatocellular carcinoma.